Sware is hosting an executive roundtable in New York City featuring CIOs and CTOs from pharma, biotech, and CDMO organizations to discuss mitigating validation risk in the AI era.
Published
Signal category
Presence & Recognition
Quote
“Sware is bringing together a select group of CIOs and CTOs from pharma, biotech, and CDMO organizations for an executive roundtable in New York City: ”
— Sware team
Company
Sware
Validation as infrastructure and process automation for healthcare, life sciences, medical device & regulated sectors.
- Industry
- Software Development
- Location
- Boston, US
- Company size
- 69 employees
Sware is the company behind Res_Q, the intelligent GxP validation platform that empowers life sciences leaders to see further and navigate rapid technological change with confidence. By integrating agentic AI frameworks with deep human expertise, Res_Q unifies workflows, uncovers operational insights, and ensures every decision is explainable, traceable, and reversible. Backed by Sware's leadership team, with over two decades of solving complex compliance challenges, the platform enables Quality, IT, and Digital Transformation leaders to spend less time on admin work and accelerate mission-critical results. Learn more at sware.com.
Founded 2015